PUBLIC HEALTH / STATE OF THE ART PAPER
Progress in caring for cancer patients in the scope of quality of life assessment
 
More details
Hide details
1
Department of Cancer Prevention, Medical University of Warsaw, Poland
 
2
Department of Health Economics and Medical Law, Medical University of Warsaw, Poland
 
 
Submission date: 2020-08-08
 
 
Final revision date: 2020-10-02
 
 
Acceptance date: 2020-11-19
 
 
Online publication date: 2021-01-31
 
 
Publication date: 2026-08-28
 
 
Corresponding author
Ewelina Nawojska   

Department of Cancer Prevention, Medical University of Warsaw, Żwirki i Wigury 61, 02-091, Warszawa, Poland
 
 
Arch Med Sci 2026;22(4):2286-2294
 
KEYWORDS
TOPICS
ABSTRACT
Quality of life is assessed using standardised general or specific ques­tion­naires. The use of such tools in scientific research makes it possible to determine how the patient functions in specific domains of life, and to measure the overall quality of life and health. A significant step forward in the approach to quality of life assessment is to also take into account factors relating to the patient’s feelings and opinions as well as objective health-related factors. The patient is treated as an entity actively participating in the diagnostic and therapeutic process, whose subjective experiences are important. Research on quality of life assessment constitutes an essential element in the evaluation of the effectiveness of medical technologies. It also represents a new approach to formulating methods of dealing with patients, which is particularly crucial in care for chronically ill patients, including cancer patients.
REFERENCES (32)
1.
Schipper H. Quality of life: principles of the clinical paradigm. J Psychosocial Oncol 1990; 8: 171-85.
 
2.
The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-9.
 
3.
Paraskevi T. Quality of life: definition and measurement. Eur J Psychol 2013; 9: 150-62.
 
4.
Chmaj-Wierzchowska K, Rzymski P, Wojciechowska M, Parda I, Wilczak M. Health-related quality of life (Nottingham Health Profile) in patients with endometriomas: correlation with clinical variables and self-reported limitations. Arch Med Sci 2020; 16: 584-91.
 
5.
Allison PJ, Locker D, Feine JS. Quality of life: a dynamic construct. Soc Sci Med 1997; 45: 221-30.
 
6.
Moorey S, Greer S. Psychological therapy for patients with cancer. New York: Oxford: Heinemann Medical Books; 1989.
 
7.
Czerw A, Marek E, Deptała A. The use of the Mini-MAC Scale in the evaluation of mental adjustment to cancer. Contemp Oncol 2015; 19: 414-9.
 
8.
Zucca A, Lambert S, Boyes A, Pallant J. Rasch analysis of the Mini-Mental Adjustment to Cancer Scale (mini-MAC) among a heterogeneous sample of long-term cancer survivors: A cross-sectional study. Health Qual Life Outcomes 2012; 10: 55.
 
9.
World Health Organization. Division of Mental Health and Prevention of Substance Abuse. WHOQOL Measuring Quality of Life. Programme on mental health. Geneva: World Health Organization; 1997.
 
10.
Arora NK. Interacting with cancer patients: the significance of physicians’ communication behaviour. Soc Sci Med 2003; 57: 791-806.
 
11.
Prieto L, Sacristan J. Problems and solutions in calculating quality-adjusted life years (QALYs). Health Qual Life Outcomes 2003; 1: 80.
 
12.
Kaplan RM, Anderson JP. The General Health Policy Model: An Integrated Approach. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1996. p. 309-22.
 
13.
Chen TH, Li L, Kochen MM. A systematic review: how to choose appropriate health-related quality of life (HRQOL) measures in routine general practice? J Zhejiang Univ Sci B 2005; 6: 936-40.
 
14.
Lin XJ, Lin IM, Fan SY. Methodological issues in measuring health-related quality of life. Tzu Chi Med J 2013; 25: 8-12.
 
15.
Karnofsky DA, Burchenal JH. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: Evaluation of Chemotherapeutic Agents. MacLeod CM, editor. New York: Columbia University Press; 1949: 196.
 
16.
Hays R, Sherbourne C, Mazel R. User’s Manual for the Medical Outcomes Study (MOS) Core Measures of Health-Related Quality of Life. Santa Monica: RAND Corporation; 1995.
 
17.
Ware J, Kosiński M, Dewey J. How to score version 2 of the SF-36 Health Survey (Standard and Acute Forms). 3rd ed. Lincoln: Quality Metric Incorporated; 2002.
 
18.
World Health Organization. Division of Mental Health. WHOQOL-BREF. Introduction, administration, scoring and generic version of the assessment. Field Trial Version. Geneva: World Health Organization; 1996.
 
19.
The Euro Qol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
 
20.
Suárez-Llanos J, Vallejo-Torres L, García-Bello M, et al. Cost-effectiveness of the hospital nutrition screening tool CIPA. Arch Med Sci 2020; 16: 273-81.
 
21.
Szende A, Williams A. Measuring Self-Reported Population Health: An International Perspective based on EQ-5D. Rotterdam: EuroQol Group; 2004.
 
22.
Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35: 185-8.
 
23.
Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R. Measuring the quality of life of cancer patients: a concise QL-Index for use by physicians. J Chronic Dis 1981; 34: 585-97.
 
24.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
 
25.
Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996; 14: 2756-68.
 
26.
Bjelic-Radisic V, Cardoso F, Cameron D, et al. EORTC Quality of Life Group and Breast Cancer Group. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Ann Oncol 2020: 31: 283-8.
 
27.
Winters ZE, Afzal M, Rutherford C, et al. European Orga­nisation for Research and Treatment of Cancer Quality of Life Group. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction. Br J Surg 2018; 105: 209-22.
 
28.
Greimel E, Bottomley A, Cull A, et al. EORTC Quality of Life Group and the Quality of Life Unit. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 2003; 39: 1402-8.
 
29.
van Andel G, Bottomley A, Fosså SD, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 2008; 44: 2418-24.
 
30.
Gujral S, Conroy T, Fleissner C, et al. European Organi­sation for Research and Treatment of Cancer Quality of Life Group. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer 2007; 43: 1564-73.
 
31.
Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 1994; 30A: 635-42.
 
32.
Koller M, Hjermstad MJ, Tomaszewski KA, et al. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients. Ann Oncol 2017; 28: 2874-81.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top